Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ASTH · against 1,372 other Healthcare companies
Ranked #1,166 of 1,373 · scores higher than 15% of peers · safety percentile 15
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 10–19, including ASTH · Click a bar to see the companies
Mainly because of its debt / equity, current ratio and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ASTH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 1.64× | 0.24× | 9% | 33% | |
| BetaLower is better · 1,320 reported | 1.03 | 0.53 | 23% | 33% | |
| Current ratioHigher is better · 1,338 reported | 1.23× | 2.62× | 17% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 1,162 | 5.9B CNY (≈$824M) | 15 | 26 | |
| 1,163 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 70.2B JPY (≈$477M) |
| 15 |
| 59 |
| 1,164 | 37M GBP (≈$48M) | 15 |
| 1,165 | 1.2B USD | 15 | 39 |
| 1,166 | 1.8B USD | 15 | 52 |
| 1,167 | 730M USD | 15 | 11 |
| 1,168 | 468M EUR (≈$514M) | 15 | 57 |
| 1,169 | 1.8B BRL (≈$328M) | 15 | 65 |
| 1,170 | 28.9B CNY (≈$4.0B) | 15 | 51 |